Summary lodised oil (lipiodol) al., 1985). Lipiodol, an iodinated derivative of poppyseed oil, has been in use for over a decade as a vehicle for targeted cytotoxic or radiotherapeutic treatment of unresectable HCCs. When injected into the hepatic artery the oil is retained by HCCs for several weeks to over a year, but is cleared from normal liver parenchyma within 7 days (Nakakuma et al., 1979) . Trials using lipiodol in conjunction with cytotoxic drugs such as doxorubicin, epidoxorubicin, aclarubicin, 5-fluorouracil, mitomycin, cisplatin and SMANCS (a polymer of neocarzinostatin with styrene and maleic acid), or radioisotopes such as 131I have yielded improved survival rates (Bhattacharya et al., 1994) . Lipiodol ultra fluid (Laboratoire Guerbet, Roissy Charles de Gaulle, France) is manufactured by ethyl trans-esterification of poppyseed oil, and consists of mono-, di-and tri-iodinated ethyl esters of linoleic (73%), oleic (14%), palmitic (9%) and stearic (3%) acid (I Chastin Laboratoire Guerbet; personal communication) with an iodine content of 37-39% by weight.
Hepatocellular carcinoma currently carries a grim prognosis. Surgical resection and in selected cases orthotopic liver transplantation offer the only hope of cure, but over 80% of patients present with inoperable disease (Okuda et al., 1985) . Lipiodol, an iodinated derivative of poppyseed oil, has been in use for over a decade as a vehicle for targeted cytotoxic or radiotherapeutic treatment of unresectable HCCs. When injected into the hepatic artery the oil is retained by HCCs for several weeks to over a year, but is cleared from normal liver parenchyma within 7 days (Nakakuma et al., 1979) . Trials using lipiodol in conjunction with cytotoxic drugs such as doxorubicin, epidoxorubicin, aclarubicin, 5-fluorouracil, mitomycin, cisplatin and SMANCS (a polymer of neocarzinostatin with styrene and maleic acid), or radioisotopes such as 131I have yielded improved survival rates (Bhattacharya et al., 1994) . Lipiodol ultra fluid (Laboratoire Guerbet, Roissy Charles de Gaulle, France) is manufactured by ethyl trans-esterification of poppyseed oil, and consists of mono-, di-and tri-iodinated ethyl esters of linoleic (73%), oleic (14%), palmitic (9%) and stearic (3%) acid (I Chastin Laboratoire Guerbet; personal communication) with an iodine content of 37-39% by weight.
Hypotheses attempting to explain lipiodol retention in HCCs fall into two major categories. One suggests that lipiodol is retained within the tumour blood vessels, which may be due to an altered electrostatic charge on the endothelial cell surface causing lipid adsorption, or impaired exit of lipid droplets due to altered drainage channels, embolisation being determined by droplet size. The other proposes that lipiodol lodges in the extracellular space, as tumour vessels are more 'leaky' than usual, and because lymphatics are absent in HCCs. Uptake by the reticuloendothelial cells in the liver, spleen, marrow and lungs is the probable route by which lipiodol is cleared when administered systemically, and HCCs may be unable to clear lipiodol because they lack a reticuloendothelial Kupffer cell component. There have been relatively few investigations into the role of the tumour cells (Javitt, 1990) . HUVECs were used instead of tumour endothelium. They share a common embryological origin with hepatic sinusoidal endothelium (Hamilton and Mossman, 1976) and also have several surface markers in common with the tumour endothelium in HCCs, namely Ulex Europeus Lectin, Factor VIII and QBendlO (Dhillon et al., 1992) . Monolayers of Hep G2 and HUVECs grown on tissue culture chamber slides were exposed for 4, 8, 24 and 32 h to culture media containing 1%, 2% and 4% of lipiodol by volume [in human subjects, bolus injection of 10 ml lipiodol over a period of 1 min into the hepatic artery, which has an average flow of 500 ml min-' (Tygstrup et al., 1962 ) is likely to yield a lipiodol concentration of 2% in the hepatic arterial blood reaching the tumour]. The iodised oil which is heavier than water, initially remained suspended as fine droplets in the aqueous medium following vigorous agitation and then settled as droplets on the surface of the cell monolayer. Following exposure to lipiodol the monolayers were stained by a silver nitrate impregnation technique adapted from Arnold et al. (1990) . This involved fixation of the cell monolayer in 10% formaldehyde, removal of excess formaldehyde by rinsing and soaking overnight in distilled water, a 1 min rinse with 70% ethanol to remove excess lipiodol adherent to the surface of the slide and further rinsing in distilled water. The monolayers were then immersed in freshly prepared silver nitrate solution (2.5% in distilled water) for 60 min in the dark at 40C. Excess silver nitrate was removed by rinsing in distilled water and the slides were counterstained with Carazzi's haematoxylin. This technique selectively stains lipiodol a golden brown colour to the exclusion of endogenous intracellular lipids. The optical density of the stained monolayers could therefore be expected to correlate with the degree of lipiodol retention. A computerised video image analysis system (Williams et al., 1986) was used to obtain an objective measure of the optical density of staining and thereby calculate the average staining intensity per cell (i.e. a reflection of lipiodol accumulation in each cell).
Assessment of lipiodol retention by tumours in vivo was carried out in three distinct clinical situations.
(1) Eight patients with solitary resectable HCC received hepatic arterial injection of a lipiodol-epirubicin emulsion as adjuvant therapy 1 -3 weeks before surgery. The resected lesions were stained with 2.5% silver nitrate using a silver impregnation technique adapted from Arnold et al. (1990) . Formalin-fixed tissue was cut into blocks 1 mm thick and immersed in distilled water for 18 h to wash out the formalin. The blocks were then immersed in 2.5% silver nitrate for 1 h in darkness. Excess silver nitrate was removed by rinsing in distilled water and the specimens were processed in alcohol for routine haematoxylin and eosin staining.
(2) The effect of lipiodol without associated cytotoxic agents was assessed in 37 patients with chronic liver disease who were given lipiodol at the time of routine hepatic arteriography before liver transplantation to identify occult HCCs. When the livers were subsequently removed, they were sliced (breadloafed) into 1-cm-thick serial sections and soft tissue radiographs were taken of every slice that contained any unusual lesion on naked-eye examination. All foci of lipiodol retention, as judged on soft tissue radiographs, were sampled for histological analysis. Fifteen hitherto undetected HCCs were discovered in four of these livers and these were stained with silver nitrate. However, there was a gap of 1-6 weeks between lipiodol angiography and removal of the livers at transplantation. (3) To assess the effect of lipiodol on tumour cells immediately after injection, 12 livers that had not received lipiodol before transplantation were flushed with a 20 ml emulsion of lipiodol (equal volumes of lipiodol and 0.9% saline agitated before injection) via the hepatic artery ex vivo within 15 min of removal, while the cells could be considered hypoxic but still viable and processed in similar fashion (formalin fixation, serial sectioning, soft tissue radiographs and silver impregnation of all foci of lipiodol uptake). A hitherto undetected 3 cm HCC was found in one of these livers and this avidly took up lipiodol.
Results
Hep G2 and HUVECs monolayers exposed to lipiodol (n = 30) consistently demonstrated intracellular golden brown vesicles of lipiodol on silver nitrate impregnation (Figure la  and b) . In cells unexposed to lipiodol there were no comparable vesicles. Apart from this, the two groups were similar in cell numbers, appearances of individual cells and their nuclei, and the configuration of cells on the surface of the slide. Transmission electron microscopy (TEM) of Hep G2 cells exposed to lipiodol revealed unusual multiple intracellular vesicles (Figure lc) . Their appearance and their consistent absence in the control cells unexposed to lipiodol indicated that these intracellular vesicles were representative of incorporated lipiodol or some derivative thereof. Inspection at high magnification indicated that these were membrane-bound vesicles, suggesting pinocytosis as a likely mechanism of incorporation. Some of the vesicles were seen in association with lysosomes. The presence of these vesicles was not associated with any evidence of cellular injury.
The optical density of every monolayer exposed to lipiodol, as quantitated by image analysis, was compared to the optical densities of the corresponding 'control' monolayers (n = 10 for each time period and concentration). For both cell types in every instance exposure to lipiodol was associated with an increase in optical density. Hep G2 cells aI ;* Figure 1 Light microscopic appearance of (a) Hep G2 and (b) HUVECs exposed to 2% lipiodol for 24h showing golden brown cytoplasmic vesicles of lipiodol. Fixation in formalin was followed by immersion in distilled water and a rinse in 70% ethanol for 1 min to remove excess lipiodol adherent to the surface. demonstrated a slow rate of uptake initially followed by progressive intracellular accumulation. HUVECs showed a rapid initial uptake, but subsequently the optical densities diminished, indicating that lipiodol had been excreted or metabolised by the cells (Figure 2 ). The rate of cellular lipiodol uptake also depended on the concentration of lipiodol in the medium. Lipiodol incorporation had no statistically significant effect on Hep G2 cell viability (trypan blue exclusion and lactate dehydrogenase release), cell numbers (measured by cell counts) and cellular protein metabolism (3H-labelled leucine uptake). Histological analysis of the eight resected HCCs showed complete tumour necrosis in one specimen. The other seven showed droplets of lipiodol localised within a majority of tumour vessels. The appearances indicated that apart from being present within the lumen, lipiodol had been incorporated by the endothelial cells lining these vessels (Figure 3) . Areas of necrosis were seen circumferentially extending around the vessels that contained lipiodol, which may represent the cytotoxic effect of epirubicin or a hypoxic effect following endothelial injury or lipid embolisation. No comparable changes were present in the 'non-tumour' liver parenchyma.
Similar observations were made in the HCCs found in explant livers removed at transplantation. Lipiodol was present in the lumen of the majority of tumour vessels, in the endothelial cells lining these vessels and in tumour cells surrounding these vessels. However, there were few areas of perivascular necrosis, probably reflecting the fact that these lesions had received only lipiodol and no cytotoxic agent. Of particular interest was the one lesion in an explant liver that was perfused with lipiodol ex vivo and fixed immediately thereafter. Brown intracellular vesicles of lipiodol were present in numerous tumour cells, which demonstrated a ballooned, foamy appearance. (Hussey and Tisdale, 1994) , and gamma-linoleic acid has been shown to enhance the effect of anticancer treatments (Mudan et al., 1993) ; linoleic and arachidonic acids are major constituents of lipiodol. Lipiodol is known to localise in human kidney, breast and bladder cancers; further studies are indicated to assess if cellular incorporation of lipiodol occurs in these tumours as well. Finally, the retention of lipiodol by endothelial cells in HCCs suggests a potential role for it in targeting tumour endothelium.
